Phase II evaluation of aclarubicin in refractory multiple myeloma: a Southeastern Cancer Study Group Trial.
Publication
, Journal Article
Gockerman, JP; Silberman, H; Bartolucci, AA
Published in: Cancer Treat Rep
1987
Duke Scholars
Published In
Cancer Treat Rep
ISSN
0361-5960
Publication Date
1987
Volume
71
Issue
7-8
Start / End Page
773 / 774
Location
United States
Related Subject Headings
- Naphthacenes
- Multiple Myeloma
- Middle Aged
- Male
- Humans
- Female
- Drug Evaluation
- Clinical Trials as Topic
- Antibiotics, Antineoplastic
- Aclarubicin
Citation
APA
Chicago
ICMJE
MLA
NLM
Gockerman, J. P., Silberman, H., & Bartolucci, A. A. (1987). Phase II evaluation of aclarubicin in refractory multiple myeloma: a Southeastern Cancer Study Group Trial. Cancer Treat Rep, 71(7–8), 773–774.
Gockerman, J. P., H. Silberman, and A. A. Bartolucci. “Phase II evaluation of aclarubicin in refractory multiple myeloma: a Southeastern Cancer Study Group Trial.” Cancer Treat Rep 71, no. 7–8 (1987): 773–74.
Gockerman JP, Silberman H, Bartolucci AA. Phase II evaluation of aclarubicin in refractory multiple myeloma: a Southeastern Cancer Study Group Trial. Cancer Treat Rep. 1987;71(7–8):773–4.
Gockerman, J. P., et al. “Phase II evaluation of aclarubicin in refractory multiple myeloma: a Southeastern Cancer Study Group Trial.” Cancer Treat Rep, vol. 71, no. 7–8, 1987, pp. 773–74.
Gockerman JP, Silberman H, Bartolucci AA. Phase II evaluation of aclarubicin in refractory multiple myeloma: a Southeastern Cancer Study Group Trial. Cancer Treat Rep. 1987;71(7–8):773–774.
Published In
Cancer Treat Rep
ISSN
0361-5960
Publication Date
1987
Volume
71
Issue
7-8
Start / End Page
773 / 774
Location
United States
Related Subject Headings
- Naphthacenes
- Multiple Myeloma
- Middle Aged
- Male
- Humans
- Female
- Drug Evaluation
- Clinical Trials as Topic
- Antibiotics, Antineoplastic
- Aclarubicin